The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

NCT05203172 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Binimetinib only treatment
DRUG: Encorafenib only Treatment
DRUG: Encorafenib & Binimetinib Treatment
DRUG: Treatment of Encorafenib & Binimetinib & Ribociclib
DRUG: Treatment of Encorafenib & Binimetinib & Cetuximab

Sponsor

Pfizer